Global Avian Influenza Vaccine Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Vaccine Type;

Inactivated Vaccines, Live Recombinant Vaccines, and Combination Vaccines.

By Strain;

H5, H7, and H9.

By Application;

Chicken , Turkey, and Goose & Duck.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn143880058 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Avian Influenza Vaccine Market (USD Million), 2021 - 2031

In the year 2024, the Global Avian Influenza Vaccine Market was valued at USD 169.03 million. The size of this market is expected to increase to USD 264.40 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.6%.

The global avian influenza vaccine market has seen significant growth and evolution driven by ongoing concerns over avian influenza outbreaks and the potential risks they pose to poultry populations and human health. Avian influenza, commonly known as bird flu, is caused by influenza viruses that primarily affect birds but can occasionally infect humans. The severity of these infections can range from mild symptoms to severe respiratory distress and, in some cases, fatalities.

In response to the recurrent outbreaks and the potential for global pandemics, the demand for avian influenza vaccines has steadily increased. These vaccines are crucial tools in preventing the spread of the virus among poultry populations, thereby safeguarding both animal welfare and public health. Governments, international organizations, and poultry producers worldwide have been investing in vaccination programs to mitigate the economic impact of avian influenza outbreaks and to protect food security.

The market for avian influenza vaccines is characterized by a diverse range of products catering to different strains of the virus and varying poultry species. Manufacturers continually innovate to improve vaccine efficacy, duration of immunity, and ease of administration. This includes advancements in vaccine delivery methods and formulations to enhance protective immunity and ensure compliance with regulatory standards.

The geographical distribution of the avian influenza vaccine market reflects the global nature of poultry production and the varying prevalence of avian influenza strains. Regions with intensive poultry farming, such as parts of Asia, North America, and Europe, are key markets for these vaccines. However, emerging economies with expanding poultry industries are also becoming significant contributors to market growth.

The market dynamics are influenced by factors such as outbreaks of avian influenza strains, regulatory policies governing poultry health, advancements in biotechnology, and changes in consumer awareness regarding food safety. As such, the global avian influenza vaccine market is expected to continue its growth trajectory, driven by the ongoing need for effective preventive measures against avian influenza outbreaks and the increasing importance of poultry health in the context of global food security.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Vaccine Type
    2. Market Snapshot, By Strain
    3. Market Snapshot, By Application
    4. Market Snapshot, By Region
  4. Global Avian Influenza Vaccine Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing prevalence of avian influenza outbreaks

        2. Growing demand for poultry products

        3. Government initiatives

        4. Disease control and prevention

      2. Restraints
        1. High costs associated with vaccine development

        2. Stringent regulatory approvals

        3. Limited awareness in some regions

        4. Concerns regarding vaccine safety

      3. Opportunities
        1. Emerging markets in Asia-Pacific and Latin America

        2. Development of novel vaccine technologies

        3. Collaborative efforts between governments

        4. Rising investments in research and development

    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Avian Influenza Vaccine Market, By Vaccine Type, 2021 - 2031 (USD Million)
      1. Inactivated Vaccines
      2. Live Recombinant Vaccines
      3. Combination Vaccines
    2. Global Avian Influenza Vaccine Market, By Strain, 2021 - 2031 (USD Million)
      1. H5
      2. H7
      3. H9
    3. Global Avian Influenza Vaccine Market, By Application, 2021 - 2031 (USD Million)
      1. Chicken
      2. Turkey
      3. Goose & Duck
    4. Global Avian Influenza Vaccine Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea ASEAN (Association of South East Asian Countries)
        6. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Boehringer Ingelheim International Gmbh
      2. Guangdong Wenshi Dahuanong Biotechnology Co., Ltd
      3. Ceva
      4. Yebio Bioengineering Co., Ltd
      5. Zoetis
      6. Fatro S.P.A.
      7. Cavac
      8. Tianjin Ringpu Bio-Technology Co., Ltd
      9. Pt Japfa Comfeed Indonesia Tbk
      10. Chengdu Tech-Bank Biological Products Co., Ltd
      11. Merck Animal Health
      12. Medion
      13. Avimex Animal Health
      14. Jovac
      15. Qyh Biotech Company Limited
  7. Analyst Views
  8. Future Outlook of the Market